CVB vs HLS

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CVB

CURVEBEAM FPO [CVB]

49LOW

HLS

HEALIUS FPO [HLS]

49LOW

Score Breakdown

CVB HLS
Technical
48
57
Catalyst
52
61
Sentiment
50
50
Fundamental
52
91
Momentum
49
34
Risk Gate
37
32

Key Metrics

CVB Metric HLS
$22.0MMarket Cap$400.8M
375KAvg Volume (20d)3.6M
+0.2%Short Interest+6.2%
$0.17552-Week High$1.635
$0.04552-Week Low$0.545
+6.5%Daily Change+5.0%
$0.049Entry Price$0.567
-41.8%ROE-69.3%
-133.1%Profit Margin-12.3%

Active Signals

CVB Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Drifting lower — down 5.8% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.6 quarters)
Low P/S ratio (1.8x)
Piotroski F-Score weak (2/9, low-confidence approx)

HLS Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.3x)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare CVB and HLS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CVB Full Analysis → HLS Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).